Immune Checkpoint Inhibitor Combined with Antiangiogenic Agent Synergistically Improving the Treatment Efficacy for Solid Tumors
Yong Zhou,* Zhengcheng Liu,* Ao Yu, Gefei Zhao, Baojun Chen Department of Thoracic Surgery, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, People’s Republic of China*These authors contributed equally to this workCorrespondence: Baojun Chen...
Saved in:
| Main Authors: | Zhou Y, Liu Z, Yu A, Zhao G, Chen B |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-12-01
|
| Series: | ImmunoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/immune-checkpoint-inhibitor-combined-with-antiangiogenic-agent-synergi-peer-reviewed-fulltext-article-ITT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Signatures of Solid Tumor Patients Treated With Immune Checkpoint Inhibitors: An Observational Study
by: Ling Chen, et al.
Published: (2025-01-01) -
Efficacy and safety of immune checkpoint inhibitors rechallenge in advanced solid tumors: a systematic review and meta-analysis
by: Jiahui Cao, et al.
Published: (2024-12-01) -
MATHEMATICS MODEL OF COMPACT TUMOR TO ANALYZE THE EFFECT ANTIANGIOGENIC THERAPY
by: Eristia Arfi, et al.
Published: (2024-07-01) -
Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review
by: Mi Young Lim, et al.
Published: (2025-01-01) -
Comparative Efficacy of Immune Checkpoint Inhibitors and Therapeutic Vaccines in Solid Tumors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Rasha Babiker, et al.
Published: (2025-04-01)